Laurus Labs set for 30% upside; shares gain 4% on Motilal Oswal ‘buy’ call

Motilal Oswal Financial Services reiterated its ‘buy’ rating on Laurus Labs Ltd, predicting over 30% upside with a target price of ₹1,280, expecting 16% earnings CAGR over FY26–28.

Leave a Reply

Your email address will not be published. Required fields are marked *